Edmonton, AB - TheNewswire - July 19, 2019 - Innovotech Inc. (TSXV:IOT) advises that Dr. Wolfgang Muhs has retired from the Board of Directors of the Company after many years of contributive and committed service to the Board and to Shareholders. All of us at Innovotech thank him and wish him only the best of all things ahead.
The Board has appointed Craig Milne BSc, PhD, MBA to succeed Dr. Muhs on the Innovotech Board. Dr. Milne is a serial entrepreneur, mentor and investor in Edmonton with extensive experience in strategy development, operations management, and business development. Craig is the CEO of Copperstone Technologies, a company bridging robotics, artificial intelligence and the mining industry. Craig was co-Founder and President of Stream Technologies Inc. and developed a product for agricultural imaging. Craig has proven adaptability, working with companies across a number of industry verticals. As a former Executive-in-Residence at TEC Edmonton, Craig established an accelerator program for medical diagnostics companies with a major industry partner. Craig is a member of Valhalla Angels, the University of Alberta Venture Mentoring Service, and the co-founder of Prairie Noodle Shop, an award-winning Edmonton restaurant. Craig has a PhD in stem cell biology from the University of Toronto and an MBA in Finance from the University of Alberta.
The Board looks forward to working with Mr. Milne in advancing the Company to a greater presence in the Canadian biotechnology universe.
Director & CFO
This document may contain forward-looking statements that are predictive in nature and subject to risks and uncertainties that cannot be predicted or quantified; consequently, actual results may differ materially from past results and those expressed or implied by any forward-looking statements. Factors that could cause or contribute to such risks or uncertainties include, but are not limited to: the regulatory environment including the difficulty of predicting regulatory outcomes; changes in the value of the Canadian dollar; the Company's reliance on a small number of customers including government organizations; fluctuations in operating results; government policies or actions; progress and cost of clinical trials; reliance on key strategic relationships; uncertainty related to intellectual property protection and potential costs associated with its defense; the Company's exposure to lawsuits and other matters beyond the control of management. Should known or unknown risks or uncertainties materialize, or should management's assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly make or update any forward-looking statements, except as required by applicable law.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.